Role of erlotinib in the targeted treatment of non-small-cell lung cancer in Chinese patients
Wei Li, Fei Zhou, Caicun Zhou Shanghai Pulmonary Hospital, Cancer Institute, Tongji University School of Medicine, Shanghai, People's Republic of China Abstract: Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) have been demonstrated to improve responses and clinic...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2014-02-01
|
| Series: | OncoTargets and Therapy |
| Online Access: | http://www.dovepress.com/role-of-erlotinib-in-the-targeted-treatment-of-non-small-cell-lung-can-a15796 |